Tirzepatide is a dual agonist at GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors and produces enhanced glycemic control and greater weight loss compared to many GLP-1 RAs [34]
Specifications Storage & Handling In lyophilized form, AOD-9604 research material should be stored at -20C in a sealed container, protected from moisture and direct light
For most people, this is right in the morning after they wake up
Who Should Use Caution and When to Adjust Dosing Patients with poorly controlled diabetes, recurrent yeast infections, compromised kidney function, or weakened immune systems require closer oversight when starting GLP-1 medications
The exact response depends on the medication, dose, health history, diet, activity, and individual tolerance